Latest Stock Market News

In a highly volatile trade, the 30-share BSE Sensex climbed 677 points or 0.93% to settle at 73,663. The NSE Nifty surged 203 points or 0.92% to 22,403.85.

​Walmart raised its full-year forecast and reported better-than-expected first-quarter results on Thursday, betting that easing inflation will drive stronger sales of groceries and non-essential merchandise like clothing and electronics, sending its shares to a record high.

​ State-owned gas utility GAIL (India) Ltd on Thursday reported more than tripling of its fourth quarter net profit after the natural gas transmission and petrochemical business saw a turnaround.

​Integrated technology solutions provider Redington Ltd has reported a standalone net profit for the January-March 2024 quarter at Rs 160.57 crore, the company said. The city-based company had registered a standalone net profits of Rs 124.91 crore during the corresponding quarter of previous year.

US stocks open nearly flat after CPI-driven rally

Updated at : 2024-05-16 20:55:01

Rate this item

(1 Vote)

The Dow Jones Industrial Average rose 4.34 points, or 0.01%, at the open to 39,912.34.

Long unwinding refers to the selling of positions or stocks owned for a longer period either to book profit or to exit it in anticipation of impending bearishness.

Vodafone Idea Q4 Results: ​Revenue from operations stood at Rs 10,607 crore against Rs 10,532 crore reported in the corresponding quarter of the last financial year. Its EBITDA for the quarter was reported at Rs 4,336 crore and there was an increase in subscriber base to 12.63 crore versus 12.26 crore in Q4FY23.

Sensex, Nifty bounced back from day’s lows by nearly 1%. Hitachi Energy India, Oberoi Realty, Bharti Airtel were in focus on Thursday. According to an expert, Bharti Airtel seems to be consolidating in the range of 1,295-1,360 in the last few sessions.

On the call side, there are notable OI concentrations at the 22,500 and 22,900 levels, suggesting these as resistance levels to watch, with the 22,900 level approaching all-time highs.

Mankind Pharma Q4 Results: The revenue from operations stood at Rs 2,441 crore versus Rs 2,053 crore reported in the year-ago period.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.